We have developed strong collaborations for the study of some important cancer-causing infections in Uganda.
These infections include:
- Human papillomavirus (HPV)
- Helicobacter pylori
- Hepatitis Viruses.
Much of this work has evolved into larger multi-country investigations.
We are examining:
- uptake of HPV vaccination and early impact on circulating HPV subtypes;
- characterization of H. pylori, patterns of drug resistance and associations with gastric abnormalities with a view to developing prevention trials in the future and;
- progression of Hepatitis B Virus-related liver disease and the contribution of infection to the total burden of abnormal liver function.
IFNL4 genotypes and risk of childhood Burkitt lymphoma in East Africa, Journal of Interferon & Cytokine Research, 2023
Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995-2016), International Journal of Cancer. 2023
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women, Infectious Agents and Cancer, 2022
Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa, PLOS ONE, 2021